Q2 2022 Holdings
Filed 2022-08-15 | 79 holdings | $397.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $33.6K | 6,894,345 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $38.6K | 2,794,859 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $39.7K | 1,929,201 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $44.0K | 2,255,588 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $45.3K | 2,356,934 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $47.3K | 1,276,574 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $48.6K | 1,597,966 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $49.9K | 10,648,527 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $53.3K | 8,929,690 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $58.7K | 3,203,783 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $73.4K | 4,384,805 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $78.7K | 3,530,543 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $81.5K | 4,138,758 | 0.0% |
| Merus N V | COM | N5749R100 | $92.4K | 4,081,431 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $92.6K | 9,275,158 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $114.2K | 21,751,284 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $116.0K | 8,291,988 | 0.0% |
| Calithera Biosciences Inc(CALA) | COM NEW | 13089P507 | $1.1M | 464,742 | 0.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.4M | 1,370,947 | 0.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.2M | 154,000 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.6M | 5,803,700 | 2.7% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $10.8M | 879,085 | 2.7% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $12.5M | 1,616,665 | 3.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $14.3M | 3,780,694 | 3.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $20.4M | 2,257,174 | 5.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $55.5M | 3,976,543 | 14.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $68.6M | 3,678,947 | 17.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $96.3M | 7,509,059 | 24.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $100.4M | 3,960,948 | 25.2% |